Skip to Main Content

Author Details

Sebastian M Waszak
University of California san francisco
2010
57
27
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
32051562Publisher Correction: Butler enables rapid cloud-based analysis of thousands of human genomes.Nat Biotechnol2023
35605606Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma.Neuro Oncol2023
37851269Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations.Acta Neuropathol2023
37584601Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.Cancer Discov2023
37640703Pan-cancer atlas of somatic core and linker histone mutations.NPJ Genom Med2023
37339626Enterosignatures define common bacterial guilds in the human gut microbiome.Cell Host Microbe2023
37145169ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma.Cancer Res2023
36495208Reply to Evans and Woodward.J Natl Cancer Inst2023
37195023ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma.Cancer Res2023
37004196Reply to Li and Colleagues.J Natl Cancer Inst2023
36944844Author Correction: Butler enables rapid cloud-based analysis of thousands of human genomes.Nat Biotechnol2023
36697831Author Correction: Genomic basis for RNA alterations in cancer.Nature2023
37379234Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.Neuro Oncol2023
36610996A polygenic two-hit hypothesis for prostate cancer.J Natl Cancer Inst2023
32051562Publisher Correction: Butler enables rapid cloud-based analysis of thousands of human genomes.Nat Biotechnol2023
37851269Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations.Acta Neuropathol2023
37584601Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.Cancer Discov2023
37640703Pan-cancer atlas of somatic core and linker histone mutations.NPJ Genom Med2023
35605606Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma.Neuro Oncol2023
36944844Author Correction: Butler enables rapid cloud-based analysis of thousands of human genomes.Nat Biotechnol2023
37379234Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.Neuro Oncol2023
37145169ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma.Cancer Res2023
37339626Enterosignatures define common bacterial guilds in the human gut microbiome.Cell Host Microbe2023
37004196Reply to Li and Colleagues.J Natl Cancer Inst2023
37195023ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma.Cancer Res2023
36697831Author Correction: Genomic basis for RNA alterations in cancer.Nature2023
36610996A polygenic two-hit hypothesis for prostate cancer.J Natl Cancer Inst2023
36495208Reply to Evans and Woodward.J Natl Cancer Inst2023
34759345Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies.Oncogene2022
35659150Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study.Eur Urol2022
35768194Cancer risk and tumour spectrum in 172 patients with a germline <i>SUFU</i> pathogenic variation: a collaborative study of the SIOPE Host Genome Working Group.J Med Genet2022
35440565A leukemia-protective germline variant mediates chromatin module formation via transcription factor nucleation.Nat Commun2022
35980168Heterozygous BRCA1 and BRCA2 and Mismatch Repair Gene Pathogenic Variants in Children and Adolescents With Cancer.J Natl Cancer Inst2022
35852795Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003.Clin Cancer Res2022
35157764Imipridones affect tumor bioenergetics and promote cell lineage differentiation in diffuse midline gliomas.Neuro Oncol2022
34759345Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies.Oncogene2022
35440565A leukemia-protective germline variant mediates chromatin module formation via transcription factor nucleation.Nat Commun2022
35768194Cancer risk and tumour spectrum in 172 patients with a germline <i>SUFU</i> pathogenic variation: a collaborative study of the SIOPE Host Genome Working Group.J Med Genet2022
35852795Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003.Clin Cancer Res2022
35659150Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study.Eur Urol2022
35980168Heterozygous BRCA1 and BRCA2 and Mismatch Repair Gene Pathogenic Variants in Children and Adolescents With Cancer.J Natl Cancer Inst2022
35157764Imipridones affect tumor bioenergetics and promote cell lineage differentiation in diffuse midline gliomas.Neuro Oncol2022
33336683Mechanisms of imipridones in targeting mitochondrial metabolism in cancer cells.Neuro Oncol2021
33630765Versatile workflow for cell type-resolved transcriptional and epigenetic profiles from cryopreserved human lung.JCI Insight2021
33953289Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas.Leukemia2021
33336683Mechanisms of imipridones in targeting mitochondrial metabolism in cancer cells.Neuro Oncol2021
33630765Versatile workflow for cell type-resolved transcriptional and epigenetic profiles from cryopreserved human lung.JCI Insight2021
33953289Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas.Leukemia2021
31609649Germline <i>GPR161</i> Mutations Predispose to Pediatric Medulloblastoma.J Clin Oncol2020
32268084Genome-wide Screens Implicate Loss of Cullin Ring Ligase 3 in Persistent Proliferation and Genome Instability in TP53-Deficient Cells.Cell Rep2020
  • 1 - 50 of 114

Recommended Authors

Marta Gut
Universitat de Barcelona (UB)
Career Start Year 2010
Number of shared co-authors 31
Christopher DeBoever
Stanford University
Career Start Year 2010
Number of shared co-authors 2
Benjamin J Kelly
Nationwide Children's Hospital
Career Start Year 2009
Number of shared co-authors 3
Mark J Cowley
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2006
Number of shared co-authors 20
Alison Meynert
Institute of Genetics and Cancer, University of Edinburgh
Career Start Year 2006
Number of shared co-authors 1
Yongjun Zhao
Canada British Columbia Cancer Research Centre, University of British Columbia
Career Start Year 2005
Number of shared co-authors 38
Daniel C Koboldt
Institute for Genomic Medicine, Nationwide Children's Hospital
Career Start Year 2005
Number of shared co-authors 9
Minjie Luo
Children's Hospital of Philadelphia
Career Start Year 2004
Number of shared co-authors 6
David W Craig
University of Southern California
Career Start Year 2004
Number of shared co-authors 14
Chip Stewart
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 26
David E Larson
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2003
Number of shared co-authors 4
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 1
Peter Van Loo
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 31
Kai Wang
University of Pennsylvania
Career Start Year 2001
Number of shared co-authors 2
Peter J Park
Harvard Medical School
Career Start Year 2001
Number of shared co-authors 29
Stacey Gabriel
Broad Institute of MIT and Harvard
Career Start Year 2001
Number of shared co-authors 31
Brent S Pedersen
Center for Molecular Medicine, University Medical Center Utrecht
Career Start Year 2001
Number of shared co-authors 0
Paul Scheet
University of Texas M.D. Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 9
Nancy F Hansen
National Human Genome Research Institute, National Institutes of Health
Career Start Year 2000
Number of shared co-authors 8
Xiang Chen
St. Jude Children's Research Hospital
Career Start Year 1999
Number of shared co-authors 18
Michael N Edmonson
St. Jude Children's Research Hospital
Career Start Year 1999
Number of shared co-authors 16
Nuria Lopez-Bigas
Universitat Pompeu Fabra
Career Start Year 1999
Number of shared co-authors 22
Martin Hirst
University of British Columbia
Career Start Year 1998
Number of shared co-authors 43
Carrie Sougnez
The Broad Institute of Harvard and MIT
Career Start Year 1998
Number of shared co-authors 20
John V Pearson
QIMR Berghofer Medical Research Institute
Career Start Year 1996
Number of shared co-authors 25
Jay Shendure
University of Washington
Career Start Year 1996
Number of shared co-authors 10
Peter C Scacheri
Case Western Reserve University School of Medicine
Career Start Year 1995
Number of shared co-authors 23
Robert S Fulton
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1994
Number of shared co-authors 28
David A Wheeler
Baylor College of Medicine
Career Start Year 1984
Number of shared co-authors 56
Kelly A Frazer
University of California, USA Institute for Genomic Medicine
Career Start Year 1967
Number of shared co-authors 6

Collaborators

Jan O Korbel
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers 26
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 16
Peter Lichter
German Cancer Research Center (DKFZ)
Co-authored papers 11
David T W Jones
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 9
Paul A Northcott
St Jude Children's Research Hospital
Co-authored papers 9
Joachim Weischenfeldt
University of Copenhagen
Co-authored papers 8
Marcel Kool
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 8
Andrey Korshunov
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 7
Christian P Kratz
Co-authored papers 7
Roland Eils
Berlin Institute of Health (BIH) and Charite
Co-authored papers 7
Javad Nazarian
USA University of Zurich
Co-authored papers 7
Ivo Buchhalter
German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Co-authored papers 7
Sabine Mueller
University Children's Hospital Zurich
Co-authored papers 7
Matthew D Dun
Co-authored papers 6
Natalie J??ger
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 6
Adrian M St??tz
St. Anna Children's Cancer Research Institute (CCRI)
Co-authored papers 6
Benedikt Brors
German Cancer Research Center (DKFZ)
Co-authored papers 6
Olaf Witt
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 6
Emmanouil T Dermitzakis
University of Geneva
Co-authored papers 5
Maia Segura-Wang
Co-authored papers 5
Stefan Rutkowski
University Medical Center Hamburg-Eppendorf
Co-authored papers 5
Marina Ryzhova
N.N. Burdenko Neurosurgical Institute
Co-authored papers 5
Tobias Rausch
University of Heidelberg
Co-authored papers 5
Marc Zapatka
Co-authored papers 5
Till Milde
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 5
Giles W Robinson
St. Jude Children's Research Hospital
Co-authored papers 5
Jason E Cain
Co-authored papers 5
Matthias Schlesner
University of Augsburg
Co-authored papers 5
Chris Lawerenz
German Cancer Research Center (DKFZ)
Co-authored papers 5
Amar Gajjar
St. Jude Children's Research Hospital
Co-authored papers 5
Release 1.2